Device type · KPJ
Chamber, Oxygen, Topical, Extremity
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
KPJ
General & Plastic Surgery
Device class
Class II
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- Chamber, Oxygen, Topical, Extremity
- Product code
- KPJ
- Device class
- Class II
- Review panel
- General & Plastic Surgery
- Regulation
- 21 CFR 878.5650
- Specialty
- General & Plastic Surgery
- FDA record
- Classification database entry for KPJ
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1477-2012 · Started Apr 16, 2012 · Posted by FDA Apr 30, 2012
Reason given: Ogenix Initiated a voluntary recall for the EPIFLO-15 devices due to a mislabeling of the expiry date for this lot. Instead of March 2013, this lot carried May 2013 as the expiry date.
Cause as FDA categorized it: Labeling mix-ups
Z-1526-06 · Started Mar 24, 2006 · Posted by FDA Sep 28, 2006
Reason given: Conflicting instructions are provided in the Instructions for Use (IFU) and the Clinical Users Guide (CUG) which accompany the EpiFLO device. Consequently, the firm removed the CUG from distribution.
Cause as FDA categorized it: Other
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.